By
Michael Lewis
|
More Articles
May 10, 2012
|
Earnings season brings on a flurry of upgrades and downgrades, and it can be an all-day affair just to get through them all. Today we look at an outlet mall operator, a real estate servicer, a firearm manufacturer, and a beverage company. Should you heed Wall Street's call?
|
Company
|
Rating Change
|
Reaction as of 1 p.m. EDT
|
| Tanger Factory Outlet (NYSE: SKT ) |
Upgrade from "neutral" to "buy" |
Up more than 0.3% |
| General Growth Properties (NYSE: GGP ) |
Upgrade from "neutral" to "buy" |
Up almost 1% |
| Smith & Wesson (NYSE: SWHC ) |
Coverage initiated at "buy" |
Up almost 4% |
| Monster Beverage (Nasdaq: MNST ) |
Reiterated "buy," with price target of $82 |
Up more than 12.5% |
Source: The Wall Street Journal.
Tanger Factory Outlet
UBS upgraded Tanger Factory Outlet from "neutral" to "buy."
- Why? UBS likes the company's development pipeline and recent acquisitions, both of which should raise full-year results.
- Justified? Yes. Though the concept of a mall may go by the wayside in the near future, the outlet mall has a niche that doesn't seem to be disappearing, as deal hunters will always love to go through the racks. The stock looks richly valued today, but at 19 times forward earnings, it's much more attractive.
General Growth Properties
UBS upgraded General Growth from "neutral" to "buy."
- Why? UBS cites the dispositions of non-core assets and greater confidence in the company's management team as drivers for earnings growth.
- Justified? No. In general, I think General Growth is an industry outperformer. But I want to wait and see where it's headed with its development pipeline before I would pony up the cash. I also prefer long-term reasons for investing over "near-term catalysts."
Smith & Wesson
The Benchmark Co. initiated coverage on Smith & Wesson at "buy."
- Why? Benchmark cited higher firearm sales, which it sees as a result of the apparently growing acceptance of the idea of gun ownership, according to recent polls.
- Justified? Yes. Regardless of your opinion on gun control, the iconic gun maker is in position to take advantage of this market trend. It is an age-old company with a manufacturing process that is down to a "T."
Monster Beverage
UBS reiterated a "buy" rating, with a price target of $82.
- Why? Quarterly results crushed analyst expectations.
- Justified? No! I don't always use exclamation marks, but again, "No!" Monster has a good product line and is expanding into foreign countries with ease. That is great, and I wish it well. But at 48 times earnings and more than 30 times forward earnings, absolutely not. I would much rather own Coca-Cola (NYSE: KO ) -- a company with a proven product that will never fade from its popularity and a stock trading at half the P/E.
Ratings are often based on short-term prospects and are therefore not relevant to the long-term investor. However, we can use these to dig up useful facts about a company we may not have seen before. It's important not to let the ratings alone color your opinion of a company. As Fools often say, it's better to do the research yourself and come to your own conclusions. Keep an eye on this series to stay in the know and save the rest of your day for coffee and Facebook.
More Expert Advice from The Motley Fool
The stakes are high for Monster Beverage these days. The stock had been nothing short of a rocket, but recent developments have sent shares spiraling downward. Health scares sparked a number of investigations at the state and federal level into the energy drinks role in several fatalities. With the companys value slashed in half, investors are wondering
whether Monster Beverage is a value or a bust in the fast-growing energy drink category. Find out now in our brand-new premium research report, which details all the ins and outs you need to know about Monster Beverage, and even comes with a full year of updates to boot.
Click here now to claim your copy and start reading today.